Brief: Pure Biologics Signs Partnership Deal With Dutch Relitech
03/06/2022 11:57
June 3 (Reuters) - Pure Biologics SA PUR1.WA :
* SIGNS PARTNERSHIP DEAL WITH DUTCH RELITECH BESLOTEN
VENNOOTSCHAP
* UNDER DEAL PARTIES TO DEVELOP MEDICAL DEVICE DEDICATED FOR
PATIENTS WITH CHRONIC KIDNEY DISEASE
* COMPANY'S FINANCIAL CONTRIBUTION FOR LABORATORY STAGE
ESTIMATED
AT 450,000 ZLOTYS
Source text for Eikon: ID:nEM1JhFvVa
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects